Interventional treatment for symptomatic acute-subacute portal and superior mesenteric vein thrombosis
- PMID: 19859995
- PMCID: PMC2768881
- DOI: 10.3748/wjg.15.5028
Interventional treatment for symptomatic acute-subacute portal and superior mesenteric vein thrombosis
Abstract
Aim: To summarize our methods and experience with interventional treatment for symptomatic acute-subacute portal vein and superior mesenteric vein thrombosis (PV-SMV) thrombosis.
Methods: Forty-six patients (30 males, 16 females, aged 17-68 years) with symptomatic acute-subacute portal and superior mesenteric vein thrombosis were accurately diagnosed with Doppler ultrasound scans, computed tomography and magnetic resonance imaging. They were treated with interventional therapy, including direct thrombolysis (26 cases through a transjugular intrahepatic portosystemic shunt; 6 through percutaneous transhepatic portal vein cannulation) and indirect thrombolysis (10 through the femoral artery to superior mesenteric artery catheterization; 4 through the radial artery to superior mesenteric artery catheterization).
Results: The blood reperfusion of PV-SMV was achieved completely or partially in 34 patients 3-13 d after thrombolysis. In 11 patients there was no PV-SMV blood reperfusion but the number of collateral vessels increased significantly. Symptoms in these 45 patients were improved dramatically without severe operational complications. In 1 patient, the thrombi did not respond to the interventional treatment and resulted in intestinal necrosis, which required surgical treatment. In 3 patients with interventional treatment, thrombi re-formed 1, 3 and 4 mo after treatment. In these 3 patients, indirect PV-SMV thrombolysis was performed again and was successful.
Conclusion: Interventional treatment, including direct or indirect PV-SMV thrombolysis, is a safe and effective method for patients with symptomatic acute-subacute PV-SMV thrombosis.
Figures
References
-
- Llado L, Fabregat J, Castellote J, Ramos E, Torras J, Jorba R, Garcia-Borobia F, Busquets J, Figueras J, Rafecas A. Management of portal vein thrombosis in liver transplantation: influence on morbidity and mortality. Clin Transplant. 2007;21:716–721. - PubMed
-
- Shibahara K, Tatsuta K, Orita H, Yonemura T, Kohno H. Superior mesenteric and portal vein thrombosis caused by congenital antithrombin III deficiency: report of a case. Surg Today. 2007;37:308–310. - PubMed
-
- Soyer T, Ciftci AO, Tanyel FC, Senocak ME, Buyukpamukcu N. Portal vein thrombosis after splenectomy in pediatric hematologic disease: risk factors, clinical features, and outcome. J Pediatr Surg. 2006;41:1899–1902. - PubMed
-
- Streitparth F, Santosa F, Milz J, Gebauer B, Teichgraber U, Hamm B, Hidajat N. [Transjugular intrahepatic portosystemic shunt in patients with portal vein thrombosis] Rofo. 2008;180:899–905. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
